Pay in 4 interest-free payments of $7.02 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Key benefits Why people compare it 1 40-60% greater healing outcomes versus either peptide alone 2 Simultaneous activation of early-phase (TB-500) and mid-phase (BPC-157) repair 3 Synergistic upregulation of both VEGF/EGF and actin-migration pathways 4 Dual anti-inflammatory action: NO system modulation plus cytokine reduction 5 Single-vial reconstitution eliminates dosing variability 6 Optimized 1:1 mass ratio matching published combination protocols 7 Thorough tendon, ligament, muscle, and joint repair support 8 No emergent toxicity beyond individual component profiles Deep research About BPC-157 / TB-500 Blend This blend combines two structurally and mechanistically distinct peptides: BPC-157 (a 15-amino acid pentadecapeptide, MW ~1419 Da, sequence GEPPPGKPADDAGLV) and TB-500 (a synthetic 43-amino acid replica of Thymosin Beta-4, MW ~4921 Da)
Clinical trials have shown BR96-Dox is not associated with the typical side effects of native doxorubicin and can potentially deliver high doses of doxorubicin to antigen-expressing tumors, enabling complete remission and cure of subcutaneous human breast, lung, and colon tumors
Why 28-30 days is the standard Bacteriostatic water preservation: Bacteriostatic water contains 0.9% benzyl alcohol, which inhibits bacterial growth
Kosten TR, George TP
Since at least seven of the panels 14 members have ties to the peptide industry or clinics promoting them, its expected theyll advise removing the restrictionseven though FDA scientists in June recommended against doing so, citing insufficient evidence on the peptides effectiveness and safety
Ascorbic acid at low pH can reduce copper(II) to copper(I), disrupting the GHK-Cu chelate and potentially generating free radicals through Fenton-type chemistry
